Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma

DSpace/Manakin Repository

Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma

Citable link to this page

 

 
Title: Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma
Author: Shen, Sipeng; Wang, Guanrong; Shi, Qianwen; Zhang, Ruyang; Zhao, Yang; Wei, Yongyue; Chen, Feng; Christiani, David C.

Note: Order does not necessarily reflect citation order of authors.

Citation: Shen, Sipeng, Guanrong Wang, Qianwen Shi, Ruyang Zhang, Yang Zhao, Yongyue Wei, Feng Chen, and David C. Christiani. 2017. “Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.” Clinical Epigenetics 9 (1): 88. doi:10.1186/s13148-017-0392-9. http://dx.doi.org/10.1186/s13148-017-0392-9.
Full Text & Related Files:
Abstract: Background: DNA methylation has started a recent revolution in genomics biology by identifying key biomarkers for multiple cancers, including oral squamous cell carcinoma (OSCC), the most common head and neck squamous cell carcinoma. Methods: A multi-stage screening strategy was used to identify DNA-methylation-based signatures for OSCC prognosis. We used The Cancer Genome Atlas (TCGA) data as training set which were validated in two independent datasets from Gene Expression Omnibus (GEO). The correlation between DNA methylation and corresponding gene expression and the prognostic value of the gene expression were explored as well. Results: The seven DNA methylation CpG sites were identified which were significantly associated with OSCC overall survival. Prognostic signature, a weighted linear combination of the seven CpG sites, successfully distinguished the overall survival of OSCC patients and had a moderate predictive ability for survival [training set: hazard ratio (HR) = 3.23, P = 5.52 × 10−10, area under the curve (AUC) = 0.76; validation set 1: HR = 2.79, P = 0.010, AUC = 0.67; validation set 2: HR = 3.69, P = 0.011, AUC = 0.66]. Stratification analysis by human papillomavirus status, clinical stage, age, gender, smoking status, and grade retained statistical significance. Expression of genes corresponding to candidate CpG sites (AJAP1, SHANK2, FOXA2, MT1A, ZNF570, HOXC4, and HOXB4) was also significantly associated with patient’s survival. Signature integrating of DNA methylation, gene expression, and clinical information showed a superior ability for prognostic prediction (AUC = 0.78). Conclusion: Prognostic signature integrated of DNA methylation, gene expression, and clinical information provides a better prognostic prediction value for OSCC patients than that with clinical information only. Electronic supplementary material The online version of this article (doi:10.1186/s13148-017-0392-9) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s13148-017-0392-9
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571486/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375256
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters